![Nicholas L. Woolf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas L. Woolf
Corporate Officer/Principal chez
Association of Chartered Certified Accountants (Australia)
Profil
Nicholas L.
Woolf is a member of the Association of Chartered Certified Accountants (Australia).
He was the Chief Executive Officer of AusCann Group Holdings Ltd. from 2020 to 2021.
He was also the Chief Executive Officer of Proteolytics Pty Ltd. He served as the Executive Director & Chief Business Officer of Oxford Biomedica Plc from 2005 to 2010.
From 2010 to 2013, he was the CFO, Executive Director & VP-Corporate Development of PYC Therapeutics Ltd. He was the Chief Business Officer of Arovella Therapeutics Ltd. from 2013 to 2018.
He was an Analyst at ABN AMRO Bank NV (Broker Old) in 2005.
Woolf is a graduate of the University of Oxford.
Currently, he is a member of the Association of Chartered Certified Accountants (Australia).
Postes actifs de Nicholas L. Woolf
| Sociétés | Poste | Début |
|---|---|---|
Association of Chartered Certified Accountants (Australia) | Corporate Officer/Principal | - |
Anciens postes connus de Nicholas L. Woolf
| Sociétés | Poste | Fin |
|---|---|---|
| AUSCANN GROUP HLDGS | Directeur Général | 18/03/2021 |
| AROVELLA THERAPEUTICS LIMITED | Corporate Officer/Principal | 24/07/2018 |
| PYC THERAPEUTICS LIMITED | Directeur Financier/CFO | 30/09/2013 |
| OXFORD BIOMEDICA PLC | Directeur/Membre du Conseil | 30/06/2010 |
ABN AMRO Bank NV (Broker Old)
 ABN AMRO Bank NV (Broker Old) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 17/01/2005 |
Formation de Nicholas L. Woolf
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
ABN AMRO Bank NV (Broker Old)
ABN AMRO Bank NV (Broker Old) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Association of Chartered Certified Accountants (Australia) | |
AusCann Group Holdings Ltd.
 AusCann Group Holdings Ltd. BiotechnologyHealth Technology Engages in development and commercialization of cannabinoid-derived therapeutic products | Health Technology |
Proteolytics Pty Ltd. |
